Vimarsana
Biggest News Aggregation in the World

Page 24 - Response Authority News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Response Authority. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Response Authority Today - Breaking & Trending Today

EU health policy taking shape post-COVID-19 - Vimarsana News

EU health policy taking shape post-COVID-19

The EU is planning to consolidate clinical trial networks to support broader multinational trials that can generate more high-quality data at speed, if and when there is another pandemic threat.  In two reports published last week, the European Commission outlined its health strategy and the steps needed to be in a better position to tackle future health emergencies.

Veru Inc. (NASDAQ:VERU) Q4 2022 Earnings Call Transcript - Vimarsana News

Veru Inc. (NASDAQ:VERU) Q4 2022 Earnings Call Transcript

Operator: Good morning ladies and gentlemen, and welcome to Veru Inc.'s Investor Conference Call. All participants will be in listen-only mode.

ERA Portal Austria – EC officially adopts Horizon Europe Work Programme for 2023-2024 - Vimarsana News

ERA Portal Austria – EC officially adopts Horizon Europe Work Programme for 2023-2024

The Austrian online platform for the European Research Area (ERA) is a promotion initiative aiming at providing comprehensive information on the implementation of the ERA.

Source: era.gv.at
The EU Wants to Transfer the Costs of New Antibiotics to its Member States—They Are Right To Revolt - Vimarsana News

The EU Wants to Transfer the Costs of New Antibiotics to its Member States—They Are Right To Revolt

An important debate is taking place in Europe right now on how to fund new antimicrobials. For months it has been speculated that the European Union may move towards implementing transferable exclusivity vouchers (TEVs). In response, 14 Member States wrote to the European Commission outlining why they think its proposed policies are costly, inefficient, and will disrupt the market for generic drugs. They make three counter proposals for how new antimicrobials can be encouraged.

Source: cgdev.org
EAPM as busy as ever on the health legislative and policy areas as year draws to a close - Vimarsana News

EAPM as busy as ever on the health legislative and policy areas as year draws to a close

Greetings at the start of Advent to the European Alliance for Personalised Medicine (EAPM) update. It was the first day of December yesterday (1 December), so the festive season is gathering pace, but EAPM is as busy as ever, and it was a busy November, with EAPM in the European Parliament hosting an event as well […]